113 related articles for article (PubMed ID: 16803527)
1. Predictability of retroperitoneal lymph node metastasis by using clinicopathologic variables in surgically staged endometrial cancer.
Taskiran C; Yuce K; Geyik PO; Kucukali T; Ayhan A
Int J Gynecol Cancer; 2006; 16(3):1342-7. PubMed ID: 16803527
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
3. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
4. Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer.
Fotopoulou C; El-Balat A; du Bois A; Sehouli J; Harter P; Muallem MZ; Krätschell RW; Traut A; Heitz F
Arch Gynecol Obstet; 2015 Dec; 292(6):1321-7. PubMed ID: 25990476
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A
Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
7. To what extent should para-aortic lymphadenectomy be carried out for surgically staged endometrial cancer?
Dogan NU; Gungor T; Karsli F; Ozgu E; Besli M
Int J Gynecol Cancer; 2012 May; 22(4):607-10. PubMed ID: 22546819
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer.
Tang X; Tanemura K; Ye W; Ohmi K; Tsunematsu R; Yamada T; Katsumata N; Sonoda T
Jpn J Clin Oncol; 1998 Nov; 28(11):673-8. PubMed ID: 9861234
[TBL] [Abstract][Full Text] [Related]
9. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
10. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma.
Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M
Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132
[TBL] [Abstract][Full Text] [Related]
11. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes.
Chuang L; Burke TW; Tornos C; Marino BD; Mitchell MF; Tortolero-Luna G; Levenback C; Morris M; Gershenson DM
Gynecol Oncol; 1995 Aug; 58(2):189-93. PubMed ID: 7622103
[TBL] [Abstract][Full Text] [Related]
12. [Factors predictive of retroperitoneal lymph node metastasis in endometrial cancer].
Urzal C; Sousa R; Baltar V; Correia P; Cruz E; Pereira da Silva D
Acta Med Port; 2014; 27(1):82-7. PubMed ID: 24581197
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of malignant cervical cytology in patients with endometrial cancer.
Larson DM; Johnson KK; Reyes CN; Broste SK
Obstet Gynecol; 1994 Sep; 84(3):399-403. PubMed ID: 8058238
[TBL] [Abstract][Full Text] [Related]
15. Influence of Prognostic Factors on Lymph Node Involvement in Endometrial Cancer: A Single-Center Experience.
Widschwendter P; Bauer E; De Gregorio N; Bekes I; Janni W; Scholz C; Friedl TWP
Int J Gynecol Cancer; 2018 Jul; 28(6):1145-1152. PubMed ID: 29757871
[TBL] [Abstract][Full Text] [Related]
16. [Is there an interest in para-aortic lymphadenectomy in operable endometrial cancer?].
Bouquier J; Bricou A; Delpech Y; Tulpin L; Akerman G; Barranger E
Bull Cancer; 2010 Feb; 97(2):199-209. PubMed ID: 19812008
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
[TBL] [Abstract][Full Text] [Related]
18. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
[TBL] [Abstract][Full Text] [Related]
19. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.
Zhang C; Wang C; Feng W
Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
